Company Filing History:
1 out of 167 
1 out of 3,923 
1 out of 139 
Years Active: 2012-2017
Title: Martin Knobloch: Innovator in Pharmaceutical Dosage Forms
Introduction
Martin Knobloch is a notable inventor based in Neuhofen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 3 patents to his name, Knobloch's work focuses on improving the efficacy and delivery of pharmaceutical compounds.
Latest Patents
One of Knobloch's latest patents is a pharmaceutical dosage form for oral administration of a BCL-2 family inhibitor. This invention relates to a solid dispersion product that includes a specific compound and various pharmaceutically acceptable components. The dosage form is designed for treating proliferative disorders, showcasing Knobloch's commitment to addressing critical health issues.
Another significant patent is the melt-processed imatinib dosage form. This invention provides a dosage form that includes a melt-processed mixture of imatinib or its salts, along with polymeric binders and non-ionic surfactants. The resulting dosage forms are characterized by high drug loading and pH-independent release, which enhances their therapeutic potential.
Career Highlights
Throughout his career, Martin Knobloch has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and Novartis AG. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Knobloch has collaborated with notable professionals in the field, including Norbert Steiger and Harald Hach. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented inventions.
Conclusion
Martin Knobloch stands out as an influential inventor in the pharmaceutical sector, with a focus on creating advanced dosage forms that improve drug delivery and efficacy. His contributions are vital in the ongoing quest for innovative solutions in medicine.